Author response: Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study
Year: 2023
Type: peer-review
Source: eLife
Authors: Avner Ehrlich, Konstantinos Ioannidis, Makram Nasar, Ismaeel Abu Alkian, Yuval Daskal, Nofar Atari, Limor Kliker, Nir Rainy, Matan Hofree, Sigal Shafran Tikva, Inbal Houri, Arrigo Cicero, Chiara Pavanello, Cesare R Sirtori, Jordana B Cohen, Julio A Chirinos, Lisa Deutsch, Merav Cohen, Amichai Gottlieb, Adina Bar-Chaim, Oren Shibolet, Michal Mandelboim, Shlomo L Maayan, Yaakov Nahmias
Institutions: Barzilai Medical Center, Sheba Medical Center, Assaf Harofeh Medical Center, Broad Institute, Klarman Cell Observatory, Massachusetts Institute of Technology, Jerusalem College of Technology, Tel Aviv Sourasky Medical Center, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University of Pennsylvania, Tel Aviv University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W4321215842